Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection, Human Immunodeficiency Virus I”

727 trials

Showing 20 of 727 results

Early research (Phase 1)Study completedNCT00043511
What this trial is testing

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT01403792
What this trial is testing

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Who this might be right for
Human Immunodeficiency Virus
University of Surrey 11
Early research (Phase 1)Study completedNCT00002335
What this trial is testing

The Safety and Effectiveness of 524W91

Who this might be right for
HIV Infections
Glaxo Wellcome 18
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Early research (Phase 1)Study completedNCT00376090
What this trial is testing

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 48
Early research (Phase 1)Study completedNCT00001041
What this trial is testing

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00001445
What this trial is testing

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT01336829
What this trial is testing

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Who this might be right for
Hepatitis CHIV
Tibotec Pharmaceuticals, Ireland 33
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00000887
What this trial is testing

Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00001005
What this trial is testing

Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Not applicableStudy completedNCT00000634
What this trial is testing

A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Early research (Phase 1)UnknownNCT02762045
What this trial is testing

Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine

Who this might be right for
Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, China 36
Early research (Phase 1)Study completedNCT00001112
What this trial is testing

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Early research (Phase 1)Study completedNCT00069030
What this trial is testing

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT00000839
What this trial is testing

A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT00002012
What this trial is testing

Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients

Who this might be right for
HIV Infections
Interferon Sciences 45
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation